/SHC
SHC Stock - Sotera Health Company
Healthcare|Medical - Diagnostics & ResearchNASDAQ
$17.17+0.35%
+$0.06 (+0.35%) • Dec 19
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.86
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).67
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.47
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+8.7%upside
Target: $18.66
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SHC
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$17.00 – $17.34
TARGET (TP)$18.67
STOP LOSS$15.80
RISK/REWARD1:1.1
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.82
52W High$17.78
52W Low$9.53
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.10B | $1.05B | $1.00B | $931.48M | $818.16M |
| Gross Profit | $602.29M | $577.16M | $557.00M | $518.67M | $443.57M |
| Gross Margin | 54.7% | 55.0% | 55.5% | 55.7% | 54.2% |
| Operating Income | $297.63M | $276.69M | $248.35M | $256.73M | $206.02M |
| Net Income | $44.40M | $51.38M | $-233,570,000 | $116.88M | $-38,617,000 |
| Net Margin | 4.0% | 4.9% | -23.3% | 12.5% | -4.7% |
| EPS | $0.16 | $0.18 | $-0.83 | $0.41 | $-0.14 |
Company Overview
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
7
58%
Hold / Neutral
5
42%
Sell / Underperform
0%
Analyst Consensus🟡 Mixed
7 Bullish5 Neutral/Bearish
Price Targets
$17
Average Target
↓ 2.3% Downside
Now
$6
Low
$17
Average
$26
High
Based on 16 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 18th 2025 | William Blair | Initiation | Outperform | - |
| November 13th 2025 | BMO Capital Markets | Initiation | Outperform | $19 |
| May 5th 2025 | Goldman | Upgrade | Buy | $17 |
| December 6th 2024 | Goldman | Initiation | Neutral | $14 |
| May 21st 2024 | Piper Sandler | Initiation | Neutral | $13 |
| April 3rd 2024 | Citigroup | Upgrade | Buy | $16← $18 |
| March 25th 2024 | Jefferies | Upgrade | Buy | $15.5← $15 |
| February 6th 2024 | KeyBanc Capital Markets | Resumed | Sector Weight | - |
| June 26th 2023 | KeyBanc Capital Markets | Upgrade | Overweight | $24 |
| January 23rd 2023 | JP Morgan | Upgrade | Neutral | $18← $6 |
| January 11th 2023 | Barclays | Upgrade | Overweight | $22← $6 |
| January 11th 2023 | Wolfe Research | Upgrade | Outperform | $25 |
| November 15th 2022 | Barclays | Downgrade | Underweight | $6 |
| October 5th 2022 | Citigroup | Downgrade | Neutral | $9← $25 |
| September 26th 2022 | KeyBanc Capital Markets | Downgrade | Sector Weight | - |
Earnings History & Surprises
SHCBeat Rate
67%
Last 18 quarters
Avg Surprise
+7.6%
EPS vs Estimate
Beats / Misses
12/3
3 met exactly
Latest EPS
$0.26
Q4 2025
EPS Surprise History
Q1 24
0.0%
$0.26vs$0.26
Q2 24
-7.1%
$0.13vs$0.14
Q3 24
+11.8%
$0.19vs$0.17
Q4 24
-10.5%
$0.17vs$0.19
Q1 25
0.0%
$0.21vs$0.21
Q2 25
+16.7%
$0.14vs$0.12
Q3 25
+17.6%
$0.20vs$0.17
Q4 25
+18.2%
$0.26vs$0.22
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 29, 2026 | — | — | — | — |
Q1 2026 | Feb 26, 2026 | $0.24 | — | — | — |
Q4 2025 | Nov 4, 2025 | $0.22 | $0.26 | +18.2% | ✓ BEAT |
Q3 2025 | Aug 8, 2025 | $0.17 | $0.20 | +17.6% | ✓ BEAT |
Q2 2025 | May 1, 2025 | $0.12 | $0.14 | +16.7% | ✓ BEAT |
Q1 2025 | Feb 27, 2025 | $0.21 | $0.21 | 0.0% | = MET |
Q4 2024 | Nov 5, 2024 | $0.19 | $0.17 | -10.5% | ✗ MISS |
Q3 2024 | Aug 5, 2024 | $0.17 | $0.19 | +11.8% | ✓ BEAT |
Q2 2024 | May 2, 2024 | $0.14 | $0.13 | -7.1% | ✗ MISS |
Q1 2024 | Feb 27, 2024 | $0.26 | $0.26 | 0.0% | = MET |
Q4 2023 | Nov 1, 2023 | $0.21 | $0.21 | 0.0% | = MET |
Q3 2023 | Aug 3, 2023 | $0.18 | $0.21 | +16.7% | ✓ BEAT |
Q2 2023 | May 3, 2023 | $0.14 | $0.13 | -7.1% | ✗ MISS |
Q1 2023 | Feb 28, 2023 | $0.22 | $0.25 | +13.6% | ✓ BEAT |
Q4 2022 | Nov 2, 2022 | $0.22 | $0.23 | +4.5% | ✓ BEAT |
Q3 2022 | Aug 4, 2022 | $0.24 | $0.27 | +12.5% | ✓ BEAT |
Q2 2022 | May 5, 2022 | $0.19 | $0.22 | +15.8% | ✓ BEAT |
Q1 2022 | Mar 1, 2022 | $0.22 | $0.23 | +4.5% | ✓ BEAT |
Q4 2021 | Nov 10, 2021 | $0.20 | $0.21 | +5.0% | ✓ BEAT |
Q3 2021 | Aug 12, 2021 | $0.21 | $0.26 | +23.8% | ✓ BEAT |
Latest News
William Blair Initiates Coverage On Sotera Health with Outperform Rating
📈 PositiveBenzinga•Dec 18, 2025, 12:11 PM
BMO Capital Initiates Coverage On Sotera Health with Outperform Rating, Announces Price Target of $19
📈 PositiveBenzinga•Nov 13, 2025, 10:21 AM
Sotera Health Launches Secondary Offering Of 30M Common Shares On Behalf Of Warburg Pincus
➖ NeutralBenzinga•Nov 6, 2025, 09:54 PM
JP Morgan Maintains Neutral on Sotera Health, Raises Price Target to $16
➖ NeutralBenzinga•Nov 5, 2025, 07:44 PM
Barclays Maintains Overweight on Sotera Health, Raises Price Target to $20
📈 PositiveBenzinga•Nov 5, 2025, 06:00 PM•Also:
Piper Sandler Maintains Neutral on Sotera Health, Raises Price Target to $17
➖ NeutralBenzinga•Nov 5, 2025, 03:59 PM
SHC stock has given up its prior gain. Sotera Health shares were trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 adjusted EPS guidance above estimates.
➖ NeutralBenzinga•Nov 4, 2025, 05:02 PM
Sotera Health shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 adjusted EPS guidance above estimates.
📈 PositiveBenzinga•Nov 4, 2025, 01:49 PM
Sotera Health Raises FY2025 Adj EPS Guidance from $0.75-$0.82 to $0.81-$0.86 vs $0.79 Est; Affirms FY2025 Sales Guidance of $1.150B-$1.166B vs $1.158B Est
📈 PositiveBenzinga•Nov 4, 2025, 12:04 PM
Sotera Health Q3 Adj. EPS $0.26 Beats $0.22 Estimate, Sales $311.312M Beat $303.626M Estimate
📈 PositiveBenzinga•Nov 4, 2025, 12:02 PM
Sotera Health Announces Secondary Offering Of 20M Shares By Warburg Pincus And GTCR Affiliates
➖ NeutralBenzinga•Sep 3, 2025, 08:58 PM
Frequently Asked Questions about SHC
What is SHC's current stock price?
Sotera Health Company (SHC) is currently trading at $17.17 per share. The stock has moved +0.35% today.
What is the analyst price target for SHC?
The average analyst price target for SHC is $18.67, based on 1 analyst.
What sector is Sotera Health Company in?
Sotera Health Company operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the NASDAQ exchange.
What is SHC's market cap?
Sotera Health Company has a market capitalization of $4.88 billion, making it a mid-cap company.
Does SHC pay dividends?
No, Sotera Health Company does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACLX
Arcellx, Inc.
$63.96
Mkt Cap: $3.5B
ALKS
Alkermes plc
$28.45
Mkt Cap: $4.7B
BLCO
Bausch + Lomb Corporation
$16.98
Mkt Cap: $6.0B
GKOS
Glaukos Corporation
$116.22
Mkt Cap: $6.7B
MMSI
Merit Medical Systems, Inc.
$87.70
Mkt Cap: $5.2B
OPCH
Option Care Health, Inc.
$32.51
Mkt Cap: $5.4B
OSCR
Oscar Health, Inc.
$14.90
Mkt Cap: $3.8B
PTGX
Protagonist Therapeutics, Inc.
$86.05
Mkt Cap: $5.4B
TFX
Teleflex Incorporated
$121.89
Mkt Cap: $5.4B
TMDX
TransMedics Group, Inc.
$127.67
Mkt Cap: $4.4B
Explore stocks similar to SHC for comparison